SOUTH ORANGE, N.J., April  16, 2026  (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced an expansion

NEPH

Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership

Nephros Targets $25 Million Opportunity in New York City Market with New Hire

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>SOUTH ORANGE, N.J., April  16, 2026  (GLOBE NEWSWIRE) -- Nephros, Inc. (NASDAQ:NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced an expansion</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Nephros Inc. is expanding its strategic focus in the Greater New York City area by appointing Dana Cunningham as a regional sales leader. The company estimates a $25 million annual addressable market opportunity for its filtration solutions, aligning with increasing regulatory focus on water quality in healthcare facilities, which could drive significant revenue growth.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Nephros expands focus in Greater New York City market.</li><li>Dana Cunningham appointed as regional sales leader.</li><li>Addressable market opportunity estimated at $25 million annually.</li><li>Growing focus on water quality in healthcare driving business potential.</li><li>Localized strategy aims to enhance customer relationships and market penetration.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Nephros, Inc. (NEPH)</strong>: Positioned for growth in water quality solutions within healthcare.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>This announcement falls under Corporate Developments as it highlights a strategic expansion into a lucrative market. The focus on regional sales leadership is crucial for leveraging local opportunities and addressing specific market needs.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Nephros estimates a $25 million annual opportunity in New York City.</li><li>New regional leadership could accelerate sales growth in healthcare markets.</li><li>Increasing regulatory scrutiny on water quality is favorable for Nephros.</li><li>Demand for water filtration systems is rising due to healthcare facility needs.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Dana Cunningham appointed regional sales leader.</li><li>Greater New York City is a key market for Nephros.</li><li>$25 million annual addressable market opportunity identified.</li><li>Nephros focuses on waterborne pathogen risk management.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Buy NEPH for exposure to growth in healthcare water solutions over the next 12 months.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="justify">SOUTH ORANGE, N.J., April  16, 2026  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=ti8Cq7GfOp_pwsbFQJpF54tz5V4VJJOrbNYfeFGxfz7zMhQC06TmRgv2qbQcNhCHxmjEcZ2etJHeSHJgABZDIQ==" rel="nofollow" target="_blank">Nephros, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/NEPH">NEPH</a>), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced an expansion of its strategic focus in the Greater New York City region with the addition of Dana Cunningham as a dedicated regional sales leader.</p>  <p align="justify">The Greater New York market represents one of the most densely populated and infrastructure-intensive regions in the United States, with a high concentration of healthcare facilities, aging water systems, and increasing regulatory and operational focus on waterborne pathogen risk. Based on internal estimates, Nephros believes this region represents a $25 million annual addressable opportunity for point-of-use filtration and related services and represents a key driver of future growth.</p>  <p align="justify">Ms. Cunningham brings more than a decade of experience in sales leadership to the New York City and Long Island region, including leadership roles across telecommunications, healthcare distribution, and insurance services. She was first introduced to Nephros products while supporting healthcare customers with infection prevention initiatives, including Legionella response efforts.</p>  <p align="justify">"Having seen firsthand how critical water quality is to patient safety and facility operations, I'm excited to join a company whose solutions make a meaningful difference," said Dana Cunningham. "Nephros stands out for both the performance of its products and the expertise of its team."</p>  <p align="justify">Nephros' decision to establish dedicated coverage in the region reflects a targeted strategy to increase penetration in high-value markets where regulatory scrutiny, infrastructure complexity, and risk awareness are converging.</p>  <p align="justify">"At Nephros, we are intentionally focusing resources on markets where the need for advanced water quality solutions is both immediate and growing," said Robert Banks, President and CEO of Nephros. "The Greater New York region is a prime example of how increasing attention to water safety in a complex region will allow us to scale. Dana's deep regional experience positions us to better serve customers and accelerate our growth in this important market."</p>  <p align="justify">With a localized, hands-on approach, Cunningham will focus on expanding relationships with healthcare systems, commercial facilities, and channel partners, supporting customers in proactively managing water quality risks through Nephros' differentiated filtration solutions.</p>  <p align="justify">This expansion aligns with Nephros' broader growth strategy to deliver value through a combination of innovative products, responsive service, and deep domain expertise, enabling customers to proactively manage water quality and reduce risk to drive increased adoption across key markets.</p>  <p align="justify"><strong>About Nephros</strong><br></br>Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Nephros products serve the needs of customers within healthcare and commercial markets, offering both proactive and emergency solutions for water management.</p>  <p align="justify">For more information about Nephros, please visit <a href="https://www.globenewswire.com/Tracker?data=DhspfX_9w-QZ3V6MHXxsZ2YalHIk17u6TucrdmnsrcLkG0pr7vSYSazIJjgHIDmFfFZa0r2kguNm91jpmtLALA==" rel="nofollow" target="_blank">nephros.com</a>.</p>  <p align="justify"><strong>Forward-Looking Statements</strong><br></br>This release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding Nephros' beliefs regarding the size of the Greater New York City market for its products, the expected benefits that Nephros will realize by its expanded focus into the Greater New York City market, the expected benefits that Nephros will realize from its water management program consulting service offering, , and other statements that are not historical facts, including statements that may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including Nephros' ability to further develop its sales organization and realize increased revenues, the extent to which financial results based on emergency response sales can be outside Nephros' control, U.S. tariff and trade policy, inflationary factors and other economic and competitive conditions, the availability of capital when needed, dependence on third-party manufacturers and researchers, and regulatory reforms. These and other risks and uncertainties are detailed in Nephros' reports filed with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2025. You should not place undue reliance on forward-looking statements. Each forward-looking statement speaks only as of the date of this release, and Nephros does not undertake any responsibility to update any forward-looking statements that it makes, except as may be required by law.</p>  <p align="justify"><strong>Investor Relations Contacts:</strong><br></br>Kirin Smith, President<br></br>PCG Advisory, Inc.<br></br>(646) 823-8656<br></br><a href="https://www.globenewswire.com/Tracker?data=Pr9FCq8-AxpNNxCAfMAy82-dHHlvFYqZsJgFp-96M2Gv3EKP8HxRML-nR9RDUaMoLmCdRQgSg6F09nloRSsEQ7hHQgPbeGCuGpz_8vSYRTo=" rel="nofollow" target="_blank">ksmith@pcgadvisory.com</a></p>  <p align="left">Robert Banks, CEO<br></br>Nephros, Inc.<br></br>(201) 343-5202 x110<br></br><a href="https://www.globenewswire.com/Tracker?data=jffeQzHtc7kInhK1wJ-7zhr8dzw_VNCW5F5WQZBV5ox6Z8VAYIATVVgLTc8Vw_SURjJ-hrs3gXadheevbaCoehJthP7gumettVPyezQa0wSWMIJah7_kN5TpfCyP8NJE" rel="nofollow" target="_blank">robert.banks@nephros.com</a></p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTY5MTM0MCM3NTM5Njk3IzUwMDE1MDA4NA=="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/ZWM2ZGVkOGUtNGRkYi00MGIwLWE1NDktY2I1ODliYWMyMGExLTUwMDE1MDA4NC0yMDI2LTA0LTE2LWVu/tiny/Nephros-Inc-.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/47f2ed6d-a81f-4174-a3eb-0a46a538285e"><img src="https://ml.globenewswire.com/media/47f2ed6d-a81f-4174-a3eb-0a46a538285e/small/logo-png.png" border="0" width="150" height="23" alt="Primary Logo"></img></a></p>

Nephros Inc. is expanding its strategic focus in the Greater New York City area by appointing Dana Cunningham as a regional sales leader. The company estimates a $25 million annual addressable market opportunity for its filtration solutions, aligning with increasing regulatory focus on water quality in healthcare facilities, which could drive significant revenue growth.

Nephros Expands Strategic Focus in Greater New York Market with Dedicated Regional Leadership

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News